Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03772873 · ClinicalTrials.gov registry record
MIPE for Pilonidal Disease
A clinical trial of Pilonidal Disease and Pilonidal Cyst/Fistula, sponsored by Northwell Health.
- Active
- Registry status
- 151
- Enrollment target
- 10
- Study locations
NCT03772873: Active study of Pilonidal Disease and Pilonidal Cyst/Fistula, sponsored by Northwell Health.
NCT03772873 is a study of Pilonidal Disease and Pilonidal Cyst/Fistula that is active but no longer recruiting, run by Northwell Health. The registered enrollment target is 151 participants, above the 119-participant average among 5 other Pilonidal Disease trials with a reported enrollment target (27% higher). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03772873, a study of Pilonidal Disease and Pilonidal Cyst/Fistula, is active but no longer recruiting, sponsored by Northwell Health.
- ACTIVE NOT RECRUITING
- Registry status
- 151 participants
- Enrollment target
- 10
- Study locations
Study Summary
Pilonidal disease often presents as a chronic, relapsing condition. A variety of procedures are used in the management of pilonidal disease, with varying degrees of morbidity, disease-free interval, and long-term success. In patients with new-onset or recurrent pilonidal disease, the investigators aim to address how minimally invasive trephine excision compares to other surgical procedures in terms of short- and long-term clinical outcomes and patient satisfaction. In the absence of a gold standard surgical procedure, surgeon preference will help dictate the management of pilonidal disease. For many surgeons, this means a variation on open excision for pilonidal disease failing conservative management. However, outcomes for minimally invasive pilonidal excision (MIPE) as initially described by Gips and forthcoming Lipskar et al., are likely to alter management of the disease (Gips, 2008). The investigators wish to assess patient and surgeon satisfaction with MIPE, and short-term outcomes.
Conditions Studied
Interventions
- PROCEDURE minimally invasive pilonidal excision
Study Locations (10)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
- Advocate Health Center - Park Ridge
Texas
- Children's Medical Center Dallas - Dallas
- Texas Children's Hospital - Houston
Maine
- Maine Medical Center - Portland
Maryland
- University of Maryland Medical Center - Baltimore
New York
- Cohen Children's Medical Center - New Hyde Park
Ohio
- Dayton Children's Hospital - Dayton
Pennsylvania
- Lehigh Valley Reilly Children's Hospital - Allentown
Tennessee
- LeBonheur Children's Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2026-06-01 |
What the registry record for NCT03772873 still lists
NCT03772873 is an observational study that tracks outcomes without assigning an intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, above the 119-participant average among 5 other Pilonidal Disease trials with a reported enrollment target (27% higher).
The record links to 10 conditions, with Pilonidal Disease appearing as the primary indexed condition, and to 1 intervention - of which minimally invasive pilonidal excision is the first listed.
NCT03772873 lists 10 locations in 8 states (Illinois, Texas, Maine).
Frequently Asked Questions
What is clinical trial NCT03772873 about?
NCT03772873 is a clinical study titled "MIPE for Pilonidal Disease". Pilonidal disease often presents as a chronic, relapsing condition. A variety of procedures are used in the management of pilonidal disease, with varying degrees of morbidity, disease-free interval, and long-term success. In patients with new-onset or recurrent pilonidal disease, the investigators a...
What is the current status of trial NCT03772873?
This trial is currently active not recruiting. The enrollment target is 151 participants. The study started on 2019-01-01. Estimated completion is 2026-06-01.
What conditions does trial NCT03772873 study?
This clinical trial studies the following conditions: Pilonidal Disease, Pilonidal Cyst/Fistula, Pilonidal Sinus Without Abscess, Pilonidal Cyst Without Abscess, Pilonidal Cyst and Sinus Without Abscess.
What interventions are being tested in trial NCT03772873?
The interventions under investigation include: minimally invasive pilonidal excision (PROCEDURE).
Who is sponsoring clinical trial NCT03772873?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03772873 being conducted?
This trial has 10 study locations across Illinois, Maine, Maryland, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pilonidal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Trial Assessing the Effectiveness of Laser Hair Depilation on Pilonidal Disease Recurrence in Patients With Darker Skin Color
RECRUITING · NA
-
Effect of Antiseptic Irrigations With 0.05% Chlorhexidine Gluconate (Irrisept) Versus Normal Saline on Fasciocutaneous Flap-Based Closure of Pilonidal Disease
RECRUITING · NA
-
Topical Anti-Androgens in Pilonidal Sinus Disease
RECRUITING · Phase 2
-
Comparing Operative vs Non Operative Treatment for Pilonidal Disease
RECRUITING · NA
-
Laser Hair Removal for Treatment of Pilonidal Disease
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI